Cardiac function, perfusion, metabolism, and innervation following autologous stem cell therapy for acute ST-elevation myocardial infarction. A FINCELL-INSIGHT sub-study with PET and MRI

Frontiers in Physiology

Volumn 3 JAN, Issue , 2012, Pages

  Mäki, Maija T ^a,b   Koskenvuo, Juha W ^a,b,c   Ukkonen, Heikki ^a,b   Saraste, Antti ^a,b   Tuunanen, Helena ^a,b   Pietilä, Mikko ^a,b   Nesterov, Sergey V ^b   Aalto, Ville ^c   Airaksinen, K E Juhani ^a,b   Pärkkä, Jussi P ^a,b   Lautamäki, Riikka ^a,b   Kervinen, Kari ^d   Miettinen, Johanna A ^d   Mäkikallio, Timo H ^d   Niemelä, Matti ^d   Säily, Marjaana ^d   Koistinen, Pirjo ^d   Savolainen, Eeva Riitta ^d   Ylitalo, Kari ^d   Huikuri, Heikki V ^d   Knuuti, Juhani ^b   more..

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

MRI; Myocardial infarct; PET; Stem cell therapy

Indexed keywords

EID: 84866296007     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00006     Document Type: Article

References (65)

1. AbdelLatif, A., Bolli, R., Tleyjeh, I. M., Montori, V. M., Perin, E. C., Hornung, C. A., ZubaSurma, E. K., Al-Mallah, M., and Dawn, B. (2007). Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch. Intern. Med. 167, 989-997.KariYlitalo
2. Amsalem, Y., Mardor, Y., Feinberg, M. S., Landa, N., Miller, L., Daniels, D., Ocherashvilli, A., Holbova, R., Yosef, O., Barbash, I. M., and Leor, J. (2007). Iron-oxide labeling and outcome of transplanted mesenchy-mal stem cells in the infarcted myocardium. Circulation 116, I38-I45.
3. Assmus, B., Schachinger, V., Teupe, C., Britten, M., Lehmann, R., Dobert, N., Grunwald, F., Aicher, A., Urbich, C., Martin, H., Hoelzer, D., Dimmeler, S., and Zeiher, A. M. (2002). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106, 3009-3017.
4. Balogh, L., Czuriga, I., Hunyadi, J., Galuska, L., Kristof, E., and Edes, I. (2007). Effects of autologous bone marrow derived CD34+ stem cells on the left ventricular function following myocardial infarction. Orv. Hetil. 148,243-249.
5. Balsam, L. B., Wagers, A. J., Chris-tensen, J. L., Kofidis, T., Weissman, I. L., and Robbins, R. C. (2004). Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428, 668-673.
6. Bartunek, J., Vanderheyden, M., Vandekerckhove, B., Mansour, S., De Bruyne, B., De Bondt, P., Van Haute, I., Lootens, N., Heyndrickx, G., and Wijns, W. (2005). Intracoro-nary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 112, I178- I183.
7. Bartunek, J., Wijns, W., Heyndrickx, G. R., and Vanderheyden, M. (2006). Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction. Nat. Clin. Pract. Cardiovasc. Med. 3(Suppl. 1), S52-S56.
8. Beeres, S. L., Bengel, F. M., Bartunek, J., Atsma, D. E., Hill, J. M., Vanderheyden, M., Penicka, M., Schalij, M. J., Wijns, W., and Bax, J. J. (2007). Role of imaging in cardiac stem cell therapy. J. Am. Coll. Cardiol. 49, 1137-1148.
9. Britten, M. B., Abolmaali, N. D., Assmus, B., Lehmann, R., Honold, J., Schmitt, J., Vogl, T. J., Martin, H., Schachinger, V., Dimmeler, S., and Zeiher, A.M. (2003). Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI) : mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 108, 2212-2218.
10. Cerqueira, M. D., Weissman, N. J., Dil-sizian, V., Jacobs, A. K., Kaul, S., Laskey, W K., Pennell, D. J., Rum-berger, J. A., Ryan, T., Verani, M. S., American Heart Association Writing Group on Myocardial Segmentation, and Registration for Cardiac Imaging. (2002). Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the american heart association. Circulation 105, 539-542.
11. Chen, S. L., Fang, W W, Ye, F., Liu, Y. H., Qian, J., Shan, S. J., Zhang, J. J., Chunhua, R. Z., Liao, L. M., Lin, S., and Sun, J. P. (2004). Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. 94, 92-95.
12. de Silva, R., Raval, A. N., Hadi, M., Gildea, K. M., Bonifacino, A. C., Yu, Z. X., Yau, Y. Y., Leitman, S. F., Bacharach, S. L., Donahue, R. E., Read, E. J., and Lederman, R. J. (2008). Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulating factor-mobilized apheresis product may not improve remodelling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarction. Eur. HeartJ. 29, 1772-1782.
13. DeFronzo, R. A., Tobin, J. D., and Andres, R. (1979). Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237, E214-E23.
14. Dill, T., Schachinger, V., Rolf, A., Mollmann, S., Thiele, H., Till-manns, H., Assmus, B., Dimmeler, S., Zeiher, A. M., and Hamm, C. (2009). Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the reinfusion of enriched progenitor cells and infarct remodeling in acute myocardial infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy. Am. Heart I 157,541-547.
15. Dobert, N., Britten, M., Assmus, B., Berner, U., Menzel, C., Lehmann, R., Hamscho, N., Schachinger, V., Dimmeler, S., Zeiher, A. M., and Grunwald, F. (2004). Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT. Eur. J. Nucl. Med. Mol. Imaging 31, 1146-1151.
16. Doyle, B., Kemp, B. J., Chareon-thaitawee, P., Reed, C., Schmeck-peper, J., Sorajja, P., Russell, S., Araoz, P., Riederer, S. J., Caplice, N. M. (2007). Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction. J. Nucl. Med. 48, 1708-1714.
17. Erbs, S., Linke, A., Schachinger, V., Assmus, B., Thiele, H., Diederich, K. W., Hoffmann, C., Dimmeler, S., Tonn, T., Hambrecht, R., Zeiher, A. M., and Schuler, G. (2007). Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the doppler substudy of the reinfusion of enriched progenitor cells and infarct remodeling in acute myocardial infarction (REPAIR-AMI) trial. Circulation 116,366-374.
18. Fernandez-Aviles, F., San Roman, J. A., Garcia-Frade, J., Fernandez, M. E., Penarrubia, M. J., de la Fuente, L., Gomez-Bueno, M., Cantalapiedra, A., Fernandez, J., Gutierrez, O., Sanchez, P. L., Hernandez, C., Sanz, R., Garcia-Sancho, J., and Sanchez, A. (2004). Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ. Res. 95, 742-748.
19. Hamacher, K., Coenen, H. H., and Stocklin, G. (1986). Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucle-ophilic substitution. J. Nucl. Med. 27,235-238.
20. Hare, J. M., Traverse, J. H., Henry, T. D., Dib, N., Strumpf, R. K., Schulman, S. P., Gerstenblith, G., DeMaria, A. N., Denktas, A. E., Gammon, R. S., Hermiller Jr, J. B., Reisman, M. A., Schaer, G. L., and Sherman, W (2009). A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54,2277-2286.
21. Hashemi, S. M., Ghods, S., Kolodgie, F. D., ParchamAzad, K., Keane, M., Hamamdzic, D., Young, R., Rippy, M. K., Virmani, R., Litt, H., and Wilen-sky, R. L. (2008). A placebo controlled, doseranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur. HeartJ. 29,251-259.
22. Herbots, L., D'hooge, J., Eroglu, E., Thijs, D., Ganame, J., Claus, P., Dubois, C., Theunissen, K., Bogaert, J., Dens, J., Kalantzi, M., Dymarkowski, S., Bijnens, B., Belmans, A., Boogaerts, M., Sutherland, G., Van de Werf, F., Rademakers, F., and Janssens, S. (2009). Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, doubleblind strain rate imaging study. Eur. Heart J. 30, 662-670.
23. Huikuri, H. V., Kervinen, K., Niemelä, M., Ylitalo, K., Säily, M., Koisti-nen, P., Savolainen, E. R., Ukkonen, H., Pietilä, M., Airaksinen, J. K., Knuuti, J., Mäkikallio, T. H., and FINCELL Investigators. (2008). Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur. Heart J. 29,2723-2732.
24. Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., Entman, M. L., Michael, L. H., Hirschi, K. K., and Goodell, M. A. (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107, 1395-1402.
25. Janssens, S., Dubois, C., Bogaert, J., Theunissen, K., Deroose, C., Desmet, W., Kalantzi, M., Herbots, L., Sinnaeve, P., Dens, J., Maertens, J., Rademakers, F., Dymarkowski, S., Gheysens, O., Van Cleemput, J., Bormans, G., Nuyts, J., Belmans, A., Mortelmans, L., Boogaerts, M., and Van de Werf, F. (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367, 113-121.
26. Kang, H. J., Lee, H. Y., Na, S. H., Chang, S. A., Park, K. W., Kim, H. K., Kim, S. Y., Chang, H. J., Lee, W., Kang, W J., Koo, B. K., Kim, Y. J., Lee, D. S., Sohn, D. W., Han, K. S., Oh, B. H., Park, Y. B., and Kim, H. S. (2006). Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by gran-ulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocar-dial infarction versus old myocar-dial infarction: the MAGIC cell-3-DES randomized, controlled trial. Circulation 114,I145-51.
27. Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., Wang, J., Homma, S., Edwards, N. M., and Itescu, S. (2001). Neovascu-larization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7, 430-436.
28. Kondo, C., Fukushima, K., and Kusakabe, K. (2003). Measurement of left ventricular volumes and ejection fraction by quantitative gated SPET, contrast ventriculography and magnetic resonance imaging: a meta-analysis. Eur. J. Nucl. Med. Mol. Imaging 6, 851-858.
29. Koskenvuo, J. W., Karra, H., Lehtinen, J., Niemi, P., Parkka, J., Knuuti, J., and Hartiala, J. J. (2007). Cardiac MRI: accuracy of simultaneous measurement of left and right ventricular parameters using three different sequences. Clin. Physiol .Funct. Imaging 27, 385-393.
30. Koskenvuo, J. W., Sakuma, H., Niemi, P., Toikka, J. O., Knuuti, J., Laine, H., Komu, M., Kormano, M., Saraste, M., and Hartiala, J. J. (2001). Global myocardial blood flow and global flow reserve measurements by MRI and PET are comparable. J. Magn. Reson. Imaging 13, 361-366.
31. Link, J. M., and Caldwell, J. H. (2008). Diagnostic and prognostic imaging of the cardiac sympathetic nervous system. Nat. Clin. Pract. Cardiovasc. Med. 5(Suppl. 2), S79-S86.
32. Lipinski, M. J., BiondiZoccai, G. G., Abbate, A., Khianey, R., Sheiban, I., Bartunek, J., Vanderheyden, M., Kim, H. S., Kang, H. J., Strauer, B. E., and Vetrovec, G. W. (2007). Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J. Am. Coll. Cardiol. 50, 1761-1767.
33. Losordo, D. W., and Dimmeler, S. (2004). Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation 109,2692-2697.
34. Lunde, K., Solheim, S., Aakhus, S., Arnesen, H., Abdelnoor, M., Egeland, T., Endresen, K., Ilebekk, A., Mangschau, A., Fjeld, J. G., Smith, H. J., Taraldsrud, E., Grogaard, H. K., Bjornerheim, R., Brekke, M., Muller, C., Hopp, E., Ragnarsson, A., Brinch-mann, J. E., and Forfang, K. (2006). Intracoronary injection of mononu-clear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 355,1199-1209.
35. Mäki, M., Luotolahti, M., Nuutila, P., Iida, H., Voipio-Pulkki, L. M., Ruot-salainen, U., Haaparanta, M., Solin, O., Hartiala, J., Härkonen, R., and Knuuti, J. (1996). Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation 93, 1658-1666.
36. Meluzín, J., Janousek, S., Mayer, J., Groch, L., Hornacek, I., Hlinomaz, O., Kala, P., Panovsky, R., Prasek, J., Kaminek, M., Stanicek, J., Klabusay, M., Koristek, Z., Navratil, M., Dusek, L., and Vinklarkova, J. (2008). Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. Int. J. Cardiol. 128, 185-192.
37. Meluzín, J., Mayer, J., Groch, L., Janousek, S., Hornácek, I., Hlinomaz, O., Kala, P., Panovský, R., Prásek, J., Kamínek, M., Stanícek, J., Klabusay, M., Korístek, Z., Navrátil, M., Dusek, L., and Vinklárková, J. (2006). Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am. HeartJ. 152,9-15.
38. Mewton, N., Revel, D., Bonnefoy, E., Ovize, M., and Croisille, P. (2011). Comparison of visual scoring and quantitative planimetry methods for estimation of global infarct size on delayed enhanced cardiac MRI and validation with myocardial enzymes. Eur. J. Radiol. 78, 87-92.
39. Meyer, G. P., Wollert, K. C., Lotz, J., Steffens, J., Lippolt, P., Fichtner, S., Hecker, H., Schaefer, A., Arseniev, L., Hertenstein, B., Ganser, A., and Drexler, H. (2006). Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113, 1287-1294.
40. Murry, C. E., Soonpaa, M. H., Reinecke, H., Nakajima, H., Nakajima, H. O., Rubart, M., Pasumarthi, K. B., Virag, J. I., Bartelmez, S. H., Poppa, V., Bradford, G., Dowell, J. D., Williams, D. A., and Field, L. J. (2004). Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428, 664-668.
41. Någren, K., Muller, L., Halldin, C., Swahn, C. G., and Lehikoinen, P. (1995). Improved synthesis of some commonly used PET radioligands by the use of [11 C]methyl triflate. Nucl. Med. Biol. 22, 235-239.
42. Nesterov, S. V., Han, C, Maki, M., Kajander, S., Naum, A. G., Helenius, H., Lisinen, I., Ukkonen, H., Pietilä, M., Joutsiniemi, E., and Knuuti, J. (2009). Myocardial perfu-sion quantitation with 15O-labelled water PET: high reproducibility of the new cardiac analysis software (carimas). Eur. J. Nucl. Med. Mol. Imaging 36, 1594-1602.
43. Nuutila, P., Mäki, M., Laine, H., Knuuti, M. J., Ruotsalainen, U., Luotolahti, M., Haaparanta, M., Solin, O., Jula, A., and Koivisto, V. A. (1995). Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. J. Clin. Invest. 96, 1003-1009.
44. Obradovic, S., Balint, B., Romanovic, R., Trifunovic, Z., Rusovic, S., Baskot, B., Dopudja, M., Trifunovic, G., Rafajlovski, S., Jung, R., and Gligic, B. (2009). Influence of intracoronary injections of bone-marrow-derived mononuclear cells on large myocardial infarction outcome: quantum of initial necrosis is the key. Vojnosanit. Pregl. 66, 998-1004.
45. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., McKay, R., NadalGinard, B., Bodine, D. M., Leri, A., and Anversa, P. (2001). Bone marrow cells regenerate infarcted myocardium. Nature AW, 701-705.
46. Pietilä, M., Malminiemi, K., Ukkonen, H., Saraste, M., Någren, K., Lehikoinen, P., and VoipioPulkki, L. M. (2001). Reduced myocardial carbon-11 hydroxyephedrine retention is associated with poor prognosis in chronic heart failure. Eur. J. Nucl. Med. 28, 373-376.
47. Pietilä, M., Malminiemi, K., Vesalainen, R., Jartti, T., Teräs, M., Någren, K., Lehikoinen, P., and VoipioPulkki, L. M. (2002). Exercise training in chronic heart failure: beneficial effects on cardiac (11)C-hydroxyephedrine PET, autonomic nervous control, and ventricular repolarization. J. Nucl. Med. 43, 773-779.
48. Rasband, W S. (2009). ImageJ v1.42q. Bethesda, MD: U. S. National Institutes of Health.
49. Rosenspire, K. C., Haka, M. S.,Van Dort, M. E., Jewett, D. M., Gildersleeve, D. L., Schwaiger, M., and Wieland, D. M. (1990). Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging. J.Nucl. Med. 31, 1328-1334.
50. Rosenzweig, A. (2006). Cardiac cell therapy - mixed results from mixed cells. N. Engl. J. Med. 355, 1274-1277.
51. Saraste, A., Koskenvuo, J. W., Saraste, M., Pärkkä, J., Toikka, J., Naum, A., Ukkonen, H., Knuuti, J., Airaksi-nen, J., and Hartiala, J. (2007). Coronary artery flow velocity profile measured by transthoracic doppler echocardiography predicts myocardial viability after acute myocardial infarction. Heart 93, 456-457.
52. Schachinger, V., Erbs, S., Elsasser, A., Haberbosch, W., Hambrecht, R., Holschermann, H., Yu, J., Corti, R., Mathey, D. G., Hamm, C. W., Suselbeck, T., Assmus, B., Tonn, T., Dimmeler, S., Zeiher, A. M., and REPAIR-AMI Investigators. (2006a). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl. J. Med. 355, 1210-1221.
53. Schachinger, V., Erbs, S., Elsasser, A., Haberbosch, W., Hambrecht, R., Holschermann, H., Yu, J., Corti, R., Mathey, D. G., Hamm, C. W., Suselbeck, T., Werner, N., Haase, J., Neuzner, J., Germing, A., Mark, B., Assmus, B., Tonn, T., Dimmeler, S., Zeiher, A. M., and REPAIR-AMI Investigators. (2006b). Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur. HeartJ. 27, 2775-2783.
54. Schwaiger, M., Kalff, V., Rosenspire, K., Haka, M. S., Molina, E., Hutchins, G. D., Deeb, M., Wolfe, E. Jr., and Wieland, D. M. (1990). Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation 82, 457-464.
55. Sipilä, H. T., Clark, J. C., Peltola, O., and Teräs, M. (2001). An automatic 15OH2O production system for heart and brain studies. J. Labelled Comp. Radiopharm. 44, S1066-S1088.
56. Strauer, B. E., Brehm, M., Zeus, T., Kos-tering, M., Hernandez, A., Sorg, R. V., Kogler, G., and Wernet, P. (2002). Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106,1913-1918.
57. Sutton, M. G., and Sharpe, N. (2000). Left ventricular remodeling after myocardial infarction: pathophysi-ology and therapy. Circulation 101, 2981-2988.
58. Tendera, M., Wojakowski, W., Ruzyllo, W., Chojnowska, L., Kepka, C., Tracz, W., Musialek, P., Piwowarska, W., Nessler, J., Buszman, P., Grajek, S., Breborowicz, P., Majka, M., Ratajczak, M. Z., and REGENT Investigators. (2009). Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre myocardial regeneration by intracoronary infusion of selected population of stem cells in acute myocardial infarction (REGENT) trial. Eur. Heart J. 30, 1313-1321.
59. Traverse, J., McKenna, D., Harvey, K., Jorgenso, B., Olson, R., Bostrom, N., Kadidlo, D., Lesser, J., Jagadeesan, V., Garberich, R., and Henry, T. (2010). Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infaction. Am. HeartJ. 160,428-434.
60. van der Bogt, K. E., Schrepfer, S., Yu, J., Sheikh, A. Y., Hoyt, G., Govaert, J. A., Velotta, J. B., Contag, C. H., Robbins, R. C., and Wu, J. C. (2009). Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation 87, 642-652.
61. van der Bogt, K. E., Sheikh, A. Y., Schrepfer, S., Hoyt, G., Cao, F., Ransohoff, K. J., Swijnenburg, R. J., Pearl, J., Lee, A., Fischbein, M., Contag, C. H., Robbins, R. C., and Wu, J. C. (2008). Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation 118, S121-S129.
62. Wollert, K. C., and Drexler, H. (2005). Clinical applications of stem cells for the heart. Circ. Res. 96, 151-163.
63. Wollert, K. C., Meyer, G. P., Lotz, J., RingesLichtenberg, S., Lippolt, P., Breidenbach, C., Ficht-ner, S., Korte, T., Hornig, B., Messinger, D., Arseniev, L., Hertenstein, B., Ganser, A., and Drexler, H. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364, 141-148.
64. Yeghiazarians, Y., Zhang, Y., Prasad, M., Shih, H., Saini, S. A., Takagawa, J., Sievers, R. E., Wong, M. L., Kapasi, N. K., Mirsky, R., Koskenvuo, J., Minasi, P., Ye, J., Viswanathan, M. N., Angeli, F. S., Boyle, A. J., Springer, M. L., and Grossman, W (2009). Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy. Mol. Ther. 17, 1250-1256.
65. Zhang, S. N., Sun, A. J., Ge, J. B., Yao, K., Huang, Z. Y., Wang, K. Q., and Zou, Y. Z. (2009). Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: a meta-analysis of randomised controlled trials. Int. J. Cardiol. 136,178-185.